We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+24.35%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$5.95B
AUM Growth
+$1.03B
Cap. Flow
-$51.9M
Cap. Flow %
-0.87%
Top 10 Hldgs %
20.89%
Holding
843
New
63
Increased
234
Reduced
384
Closed
70

Top Buys

Rank Stock Value
1
GL icon
Globe Life
GL
+$26.9M
2
VYX icon
NCR Voyix
VYX
+$19.9M
3
KSU
Kansas City Southern
KSU
+$16.1M
4
LW icon
Lamb Weston
LW
+$14.8M
5
CRL icon
Charles River Laboratories
CRL
+$13.4M

Sector Composition

Rank Sector Weight
1 Technology 22.86%
2 Healthcare 18.41%
3 Financials 11.42%
4 Industrials 10.25%
5 Consumer Discretionary 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMZN icon
1
Amazon
AMZN
$2.63T
$207M 3.47%
1,497,000
+1,320
+0.1% +$159K
MSFT icon
2
Microsoft
MSFT
$2.9T
$162M 2.72%
796,539
+4,357
+0.5% +$791K
ADBE icon
3
Adobe
ADBE
$86.8B
$161M 2.7%
369,718
-6,687
-2% -$2.48M
AAPL icon
4
Apple
AAPL
$4.79T
$157M 2.64%
1,719,792
-133,236
-7% -$10.3M
ROP icon
5
Roper Technologies
ROP
$34B
$117M 1.97%
301,493
-2,440
-0.8% -$874K
V icon
6
Visa
V
$672B
$101M 1.69%
521,797
+855
+0.2% +$156K
GOOG icon
7
Alphabet (Google) Class C
GOOG
$4.17T
$93.5M 1.57%
1,324,120
+2,580
+0.2% +$174K
ZTS icon
8
Zoetis
ZTS
$31.1B
$90.4M 1.52%
659,707
-11,433
-2% -$1.49M
MRVL icon
9
Marvell Technology
MRVL
$189B
$83M 1.4%
2,367,391
-154,387
-6% -$4.52M
MTD icon
10
Mettler-Toledo International
MTD
$26B
$71.9M 1.21%
89,322
-3,225
-3% -$2.4M
ZBRA icon
11
Zebra Technologies
ZBRA
$12.5B
$70.7M 1.19%
276,075
+26,144
+10% +$6.13M
ABT icon
12
Abbott
ABT
$175B
$66.7M 1.12%
730,095
-27,912
-4% -$2.52M
JPM icon
13
JPMorgan Chase
JPM
$926B
$64.8M 1.09%
688,846
-8,111
-1% -$770K
TMO icon
14
Thermo Fisher Scientific
TMO
$196B
$64.3M 1.08%
177,561
-1,570
-0.9% -$526K
DHR icon
15
Danaher
DHR
$127B
$64M 1.08%
408,494
+7,340
+2% +$1.05M
UNH icon
16
UnitedHealth
UNH
$392B
$61.8M 1.04%
209,569
-5,037
-2% -$1.44M
TECH icon
17
Bio-Techne
TECH
$11.2B
$61M 1.03%
924,928
-82,252
-8% -$4.93M
INFO
18
DELISTED
IHS Markit Ltd. Common Shares
INFO
$59.3M 1%
784,082
-2,352
-0.3% -$160K
CMCSA icon
19
Comcast
CMCSA
$84B
$58.4M 0.98%
1,498,334
-8,312
-0.6% -$317K
FMC icon
20
FMC
FMC
$1.48B
$56.5M 0.95%
567,828
+37,597
+7% +$3.47M
HAIN icon
21
Hain Celestial
HAIN
$51.4M
$56.3M 0.95%
1,788,065
-209,013
-10% -$6.04M
FNV icon
22
Franco-Nevada
FNV
$41.3B
$55.6M 0.93%
397,933
+5,242
+1% +$696K
GWRE icon
23
Guidewire Software
GWRE
$11.2B
$54.6M 0.92%
492,236
-167,295
-25% -$16.1M
MCHP icon
24
Microchip Technology
MCHP
$46.2B
$54.3M 0.91%
1,030,156
-102,474
-9% -$4.61M
CTLT
25
DELISTED
CATALENT, INC.
CTLT
$53M 0.89%
722,827
-172,063
-19% -$11.7M

Similar funds

Segall Bryant & Hamill's Q2 2020 Portfolio in Review

As of Q2 2020, Segall Bryant & Hamill held 843 positions worth $5.95B, up 21% from $4.92B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Segall Bryant & Hamill's Q2 2020 filing shows 63 new, 234 increased, 384 reduced and 70 closed positions. Its largest new stake was Globe Life: 354,355 shares worth $26.3M. The largest sale was FLIR Systems, Inc. (DE) Common Stock, an estimated $29.4M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Segall Bryant & Hamill's largest Q2 2020 buy was Globe Life: 354,355 shares worth $26.3M.
  • Segall Bryant & Hamill added most to NCR Voyix in Q2 2020, an estimated $19.9M increase.
  • Segall Bryant & Hamill's biggest Q2 2020 reduction was FLIR Systems, Inc. (DE) Common Stock, cutting an estimated $29.4M.
  • Segall Bryant & Hamill fully exited Raytheon Company in Q2 2020, selling an estimated $8.87M.
  • Segall Bryant & Hamill's ten largest holdings make up 21% of its $5.95B portfolio in Q2 2020.
  • Segall Bryant & Hamill opened 63 new positions and closed 70 in Q2 2020.
  • Segall Bryant & Hamill's portfolio value rose 21% quarter-over-quarter to $5.95B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2020, filed 14 Aug 2020.